- $9.80bn
- $8.91bn
- $944.61m
Annual balance sheet for Argan, fiscal year end - January 31st, USD millions except per share, conversion factor applied.
2022 January 31st | 2023 January 31st | 2024 January 31st | 2025 January 31st | 2026 January 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 440 | 325 | 412 | 525 | 895 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 31.9 | 74.9 | 95.5 | 240 | 213 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 507 | 439 | 547 | 781 | 1,132 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 14.5 | 16.5 | 18.5 | 24.5 | 24.6 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Other Long Term Assets | |||||
| Total Assets | 554 | 489 | 598 | 836 | 1,186 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 223 | 203 | 302 | 480 | 711 |
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 227 | 209 | 307 | 484 | 724 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Treasury Stock | |||||
| Other Equity | |||||
| Total Equity | 326 | 281 | 291 | 352 | 462 |
| Total Liabilities & Shareholders' Equity | 554 | 489 | 598 | 836 | 1,186 |
| Total Common Shares Outstanding |